FOR AUTHORS
Search
Search Results
##search.searchResults.foundPlural##
-
01 | End-of-life care in advanced melanoma and other skin cancers: a retrospective cohort from an Italian comprehensive cancer center Michela De Mattia1, Enrica Teresa Tanda3, Andrea Boutros2, Virginia Delucchi5, Eva Blondeaux5, Agostina Lagodin D’Amato1, Irene Giannubilo1, Lucia Del Mastro1|2, Paolo Pronzato3, Francesco Spagnolo3|4, Claudia Bighin3 | 1Dipartimento di Medicina Interna e Specialità Mediche, Università degli Studi di Genova; 2U.O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova; 3U.O. Oncologia Medica 2, IRCCS Ospedale Policlinico San Martino, Genova; 4Dipartimento di Scienze Chirurgiche e Diagnostiche Integrate, Università di Genova, Genova; 5U.O. Epidemiologia Clinica, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
458 -
Application of ChatGPT as a content generation tool in continuing medical education: acne as a test topic
1182PDF: 661SUPPLEMENTARY MATERIAL: 125HTML: 17 -
20 | How Covid-19 pandemic influenced the diagnosis of new primary melanoma: a retrospective, multicenter study by the Italian Society of Oncological Surgery Giuseppe Sciacca*1|2, Luca Nespoli1, Virginia Caliendo2, Dario Piazzalunga3, Piero Rossi4, Marco Clementi5, Corrado Caracò6, Salvatore Asero7, Matteo Mascherini8, Franco De Cian8, Francesco Russano9, Paolo Del Fiore9, Sara Coppola10, Elisabetta Pennacchioli10, Pietro Gallina11, Marzia Franzò12, Marco Rastrelli9|12 | 1General and Emergency Surgery, School of Medicine and Surgery, Milano-Bicocca University, Fondazione IRCCS San Gerardo dei Tintori, Monza; 2Department of Surgery, Dermatologic Surgery Section, Azienda Ospedaliera Universitaria Città della Salute e della Scienza, Turin; 3Unit of Surgery, Papa Giovanni XXIII Hospital, Bergamo; 4Dipartimento Di Scienze Chirurgiche, Università di Roma Tor Vergata, Policlinico Tor Vergata, Rome; 5General Surgical Unit, Department of Biotechnological and Applied Clinical Sciences, University of L’Aquila; 6Division of Surgery of Melanoma and Skin Cancer, Istituto Nazionale Tumori "Fondazione Pascale" IRCCS, Napoli; 7Soft Tissue U.O. Surgical Oncology-Soft Tissue Tumors, Dipartimento di Oncologia, Azienda Ospedaliera di Rilievo Nazionale e di Alta Specializzazione Garibaldi di Catania; 8Department of Surgical Sciences and Integrated Diagnostic DISC, University of Genoa; 9Soft-Tissue, Peritoneum and Melanoma Surgical Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padova; 10Division of Melanoma, Soft Tissue Sarcomas and Rare Tumors, European Institute of Oncology, IRCCS, Milano; 11Directorate General, Veneto Institute of Oncology IOV-IRCCS, Padua; 12Department of Surgery, Oncology and Gastroenterology, DISCOG, University of Padua, AOPD Azienda Ospedale Università Padova, Padova, Italy.
345 -
33 | A single center, real world experience with hedgehog pathway inhibitors in advanced basal cell carcinoma Giulia Gibilisco1, Ramiz Anwar Rana1, Vincenzo D’Alonzo1, Maura Colucci1|2, Monica Valente2, Elisa Cinotti3, Giovanni Rubino4, Valentina Croce1, Eleonora Carbonari1, Matteo Ravara1, Tommaso Sani1, Maria Lo Fiego1, Alessia Covre1, Serena Cutarella1, Roberto Cuomo5, Luca Grimaldi5, Pietro Rubegni3, Michele Maio1|2, Anna Maria Di Giacomo1|2 | 1University of Siena; 2Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena; 3Dermatology Unit, Department of Medicine, Surgery and Neuroscience, University Hospital of Siena; 4Radiotherapy Unit, Department of Oncology, University Hospital of Siena; 5Plastic Surgery Unit, Department of Medicine, Surgery and Neuroscience, University Hospital of Siena; 6NIBIT Foundation Onlus, Genoa, Italy.
312 -
Teledermatopathology on the ADOI platform and beyond
742PDF: 452HTML: 16 -
Rituximab for linear immunoglobulin A bullous dermatosis
1353PDF: 558HTML: 32 -
16 | Sentinel lymph node biopsy in elderly patients with melanoma: prognostic value and impact on recurrence B. Taglione1, I. Mattavelli1, A. Maurichi1, G. Gallino1, D. Cortese1, A. Manfredi1, S. Mercurio1, G. Spadola1, E. Tolomio1, C. Barbieri1, B. Scoppio1, M. Cossa2, B. Valeri2, M. Santinami1, R. Patuzzo1 | 1IRCCS Fondazione Istituto Nazionale dei Tumori di Milano, Melanoma Surgical Unit, Milano; 2IRCCS Fondazione Istituto Nazionale dei Tumori di Milano, Pathology, Milano, Italy.
313 -
Teledermatology: Canadian dermatologists’ practice patterns, perceived challenges, and future recommendations
472PDF: 243SUPPLEMENTARY MATERIAL: 30HTML: 6 -
28 | Efficacy and toxicity outcomes with doublet immunotherapy in metastatic melanoma: the real-world REALIPINIVO study Miriam Forte1, Francesco Caraglia1, Silvana Cozzolino1, Antonino Colloca1, Alfonso Esposito1, Maria Cristina Giugliano1, Eleonora Cioli1, Marcella Scala2, Francesca Sparano5, Maria Chiara Sergi3, Teresa Del Giudice4, Immacolata Paciolla6, Luigi Formisano2, Stefania Napolitano1, Antonio Maria Grimaldi6, Paolo Antonio Ascierto5, Fortunato Ciardiello1, Teresa Troiani1, Vincenzo De Falco1 | 1Medical Oncology, Department of Precision Medicine, Università degli Studi della Campania Luigi Vanvitelli, Naples; 2Department of Clinical Medicine and Surgery, Federico Il University, Naples; 3Unità Operativa Complessa di Oncologia Medica, Ospedale "Mons. A.R. Dimiccoli", Barletta; 4Nuclear Medicine Unit, "Mater Domini" University Hospital, Catanzaro; 5Istituto Nazionale Tumori IRCCS Fondazione Giovanni Pascale Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Napoli; 6Medical Oncology Unit AORN "San Pio", Benevento, Italy.
328 -
Autoinflammatory diseases: what is behind them and what is new?
1779PDF: 560HTML: 138 -
Epidermolysis bullosa acquisita: current diagnosis and therapy
1541PDF: 836HTML: 125
